Literature DB >> 7728417

Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma.

H Strohmaier1, H Hinghofer-Szalkay, R J Schaur.   

Abstract

4-Hydroxynonenal (HNE) is a major aldehydic product formed by peroxidation of omega 6-unsaturated fatty acids and is regarded as a specific marker of lipid peroxidation. In this paper we demonstrate that there is a physiological steady-state concentration of HNE in human venous blood plasma. For the quantitative determination of HNE a modified version of an existing, but tedious and time-consuming HPLC method was developed. The extraction of aldehydic hydrazones from plasma was performed using an Extrelut column and the separation step by thin-layer chromatography was replaced by column chromatography on silica gel. The concentration of HNE in human blood plasma was in the same range as the concentration that was found to inhibit the proliferation of cells of the peripheral tissues, i.e., endothelial cells and fibroblasts in vitro. In an experiment with reduced peripheral blood flow a temporary significant increase of HNE was observed during reperfusion. It was concluded that lipid peroxidation occurs in peripheral tissues of humans following temporary congestion of venous blood flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728417     DOI: 10.1016/0929-7855(94)00027-a

Source DB:  PubMed          Journal:  J Lipid Mediat Cell Signal        ISSN: 0929-7855


  27 in total

1.  gamma-Glutamyl transpeptidase is induced by 4-hydroxynonenal via EpRE/Nrf2 signaling in rat epithelial type II cells.

Authors:  Hongqiao Zhang; Honglei Liu; Dale A Dickinson; Rui-Ming Liu; Edward M Postlethwait; Yannick Laperche; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2005-12-01       Impact factor: 7.376

2.  The role of c-Jun phosphorylation in EpRE activation of phase II genes.

Authors:  Smadar Levy; Anil K Jaiswal; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2009-08-07       Impact factor: 7.376

3.  T-cell recognition of lipid peroxidation products breaks tolerance to self proteins.

Authors:  D M Wuttge; M Bruzelius; S Stemme
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  Role of physiological levels of 4-hydroxynonenal on adipocyte biology: implications for obesity and metabolic syndrome.

Authors:  Kalavathi Dasuri; Philip Ebenezer; Sun Ok Fernandez-Kim; Le Zhang; Zhanguo Gao; Annadora J Bruce-Keller; Linnea R Freeman; Jeffrey N Keller
Journal:  Free Radic Res       Date:  2012-10-16

5.  Lipophilic aldehydes and related carbonyl compounds in rat and human urine.

Authors:  S S Kim; D D Gallaher; A S Csallany
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

6.  Method for analysis of 4-hydroxy-2-(E)-nonenal with solid-phase microextraction.

Authors:  Tatsuhiro Uchida; Naohiro Gotoh; Shun Wada
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

7.  Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells.

Authors:  Hongqiao Zhang; Albert Shih; Alessandra Rinna; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2008-10-22       Impact factor: 4.013

8.  SHP-1 inhibition by 4-hydroxynonenal activates Jun N-terminal kinase and glutamate cysteine ligase.

Authors:  Alessandra Rinna; Henry Jay Forman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-02-14       Impact factor: 6.914

9.  Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress.

Authors:  M Spite; L Summers; T F Porter; S Srivastava; A Bhatnagar; C N Serhan
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

10.  Inhibition of NF-κB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Songtao Li; Zhigang Wang; Dongfang Gu; Chen Shen; Tong Yao; Zhenyuan Song
Journal:  Am J Pathol       Date:  2012-09-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.